The prognostic value of multilineage dysplasia in de novo acute myeloid leukemia patients with intermediate-risk cytogenetics is dependent on NPM1 mutational status

被引：37

作者：

Diaz-Beya, Marina

Rozman, Maria ^{[1
]}

Pratcorona, Marta ^{[1
]}

Torrebadell, Montserrat ^{[1
]}

Camos, Mireia ^{[1
]}

Aguilar, Joseph L. I.

Esteve, Jordi ^{[1
]}

机构：

[1] Hosp Clin Barcelona, Dept Hematol, IDIBAPS, Hematopathol Unit, E-08036 Barcelona, Spain

来源：

BLOOD | 2010年 / 116卷 / 26期

关键词：

CLASSIFICATION; AML; RELEVANCE; IMPACT;

D O I：

10.1182/blood-2010-09-307314

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：6147 / 6148

页数：4

相关论文

共 6 条

[1]

[Anonymous], 2008, WHO CLASSIFICATION T

[2] Prognostic impact of acute myeloid leukemia classification - Importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on survival [J].

Arber, DA ;

Stein, AS ;

Carter, NH ;

Ikle, D ;

Forman, SJ ;

Slovak, ML .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 119 (05) :672-680

[3] Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1) [J].

Falini, Brunangelo ;

Macijewski, Katja ;

Weiss, Tamara ;

Bacher, Ulrike ;

Schnittger, Susanne ;

Kern, Wolfgang ;

Kohlmann, Alexander ;

Klein, Hans-Ulrich ;

Vignetti, Marco ;

Piciocchi, Alfonso ;

Fazi, Paola ;

Martelli, Maria Paola ;

Vitale, Antonella ;

Pileri, Stefano ;

Miesner, Miriam ;

Santucci, Antonella ;

Haferlach, Claudia ;

Mandelli, Franco ;

Haferlach, Torsten .

BLOOD, 2010, 115 (18) :3776-3786

[4] Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy:: Results of a multiparameter analysis from the German AML cooperative group studies [J].

Haferlach, T ;

Schoch, C ;

Löffler, H ;

Gassmann, W ;

Kern, W ;

Schnittger, S ;

Fonatsch, C ;

Ludwig, WD ;

Wuchter, C ;

Schlegelberger, B ;

Staib, P ;

Reichle, A ;

Kubica, U ;

Eimermacher, H ;

Balleisen, L ;

Grüneisen, A ;

Haase, D ;

Aul, C ;

Karow, J ;

Lengfelder, E ;

Wörmann, B ;

Heinecke, A ;

Sauerland, MC ;

Büchner, T ;

Hiddemann, W .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (02) :256-265

[5] MLF according to the WHO classification in AML has no correlation with age and no independent prognostic relevance as analyzed in 1766 patients [J].

Wandt, Hannes ;

Schakel, Ulrike ;

Kroschinsky, Frank ;

Prange-Krex, Gabriele ;

Mohr, Brigitte ;

Thiede, Christian ;

Pascheberg, Ulrich ;

Soucek, Silke ;

Schaich, Markus ;

Ehninger, Gerhard .

BLOOD, 2008, 111 (04) :1855-1861

[6] Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system [J].

Weinberg, Olga K. ;

Seetharam, Mahesh ;

Ren, Li ;

Seo, Katie ;

Ma, Lisa ;

Merker, Jason D. ;

Gotlib, Jason ;

Zehnder, James L. ;

Arber, Daniel A. .

BLOOD, 2009, 113 (09) :1906-1908